Aquatic Capital Management’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
CAM
SI
JT
OCA
RCM
MB
PCH
Aquatic Capital Management's BIOA Position: Q2 2026 in Review
Aquatic Capital Management sold out of BioAge Labs (BIOA) in Q2 2026, closing a stake of 881 shares — an estimated $15.4K sold.
Aquatic Capital Management first reported a position in BIOA in Q1 2026 and held it in 1 quarter. The position peaked at $15.4K in Q1 2026. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.
- Aquatic Capital Management reported no remaining BioAge Labs position as of Q2 2026 after selling out during the quarter.
- Aquatic Capital Management sold 881 BioAge Labs shares in Q2 2026, an estimated $15.4K.
- Aquatic Capital Management first reported a position in BioAge Labs in Q1 2026 and held it in 1 quarter.
- Aquatic Capital Management's BioAge Labs position peaked at $15.4K in Q1 2026.
- 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.
Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.